Valuation: Kenvue Inc.

Capitalization 41.03B 35.28B 33.01B 30.11B 56.21B 3,527B 63.02B 391B 150B 1,625B 154B 151B 5,938B P/E ratio 2025 *
23.1x
P/E ratio 2026 * 19.4x
Enterprise value 48B 41.28B 38.62B 35.23B 65.77B 4,126B 73.73B 457B 176B 1,901B 180B 176B 6,948B EV / Sales 2025 *
3.08x
EV / Sales 2026 * 2.94x
Free-Float
99.66%
Yield 2025 *
3.89%
Yield 2026 * 3.95%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.68%
1 week-1.03%
Current month-11.10%
1 month-11.32%
3 months-9.20%
6 months-1.58%
Current year-0.61%
More quotes
1 week 21.03
Extreme 21.03
21.7
1 month 21.03
Extreme 21.03
24
Current year 19.75
Extreme 19.75
25.17
1 year 17.67
Extreme 17.67
25.17
3 years 17.67
Extreme 17.67
27.8
5 years 17.67
Extreme 17.67
27.8
10 years 17.67
Extreme 17.67
27.8
More quotes
Manager TitleAgeSince
Chief Executive Officer 55 2023-05-07
Director of Finance/CFO 56 2025-05-11
Chief Tech/Sci/R&D Officer 53 2023-04-30
Director TitleAgeSince
Director/Board Member 55 2023-05-07
Chairman 69 2023-04-30
Director/Board Member 65 2023-05-03
More insiders
Name Weight AuM 1st Jan change
0.09% 38 M€ +0.98% -
More ETFs: Kenvue Inc.
Change 5d. change 1-year change 3-years change Capi.($)
-0.68%-1.03%+12.28% - 41.03B
-0.75%+0.88%-5.06%+10.79% 378B
-0.17%-1.04%+3.00%+22.29% 154B
-0.78%-0.71%-11.10%+9.49% 71.86B
-0.53%-2.76%-7.30%+0.47% 61.73B
-2.97%+2.38%-33.49%-71.66% 28.36B
+0.79%-1.46%-23.74%+10.33% 27.31B
+0.31%-0.15%-6.16%-1.21% 18.6B
+0.24%-1.20%-13.49%+51.50% 13.83B
+1.63%+0.72%-19.47%-5.95% 9.58B
Average -0.19%-0.72%-10.45%+2.89% 80.38B
Weighted average by Cap. -0.52%-0.53%-5.33%+9.31%
See all sector performances

Financials

2025 *2026 *
Net sales 15.6B 13.42B 12.55B 11.45B 21.38B 1,341B 23.97B 149B 57.08B 618B 58.54B 57.31B 2,259B 16.15B 13.88B 12.99B 11.85B 22.12B 1,388B 24.8B 154B 59.07B 639B 60.57B 59.3B 2,337B
Net income 1.72B 1.48B 1.38B 1.26B 2.35B 148B 2.64B 16.36B 6.28B 68.03B 6.44B 6.31B 249B 2.13B 1.84B 1.72B 1.57B 2.92B 183B 3.28B 20.32B 7.81B 84.53B 8.01B 7.84B 309B
Net Debt 6.97B 6B 5.61B 5.12B 9.55B 599B 10.71B 66.39B 25.51B 276B 26.16B 25.61B 1,009B 6.39B 5.5B 5.14B 4.69B 8.76B 550B 9.82B 60.88B 23.39B 253B 23.99B 23.48B 926B
More financial data * Estimated data
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (41,8%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (29.9%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (28.3%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49.3%), Europe-Middle East-Africa (21.9%), Asia-Pacific (20.1%) and Latin America (8.7%).
Employees
22,000
More about the company
Date Price Change Volume
25-06-24 21.22 $ -0.70% 7,268,550
25-06-23 21.37 $ -0.09% 14,174,385
25-06-20 21.39 $ +0.14% 24,956,572
25-06-18 21.36 $ -0.37% 14,259,589
25-06-17 21.44 $ -0.97% 17,940,868

Delayed Quote Nyse, June 24, 2025 at 02:39 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
21.37USD
Average target price
24.69USD
Spread / Average Target
+15.54%
Consensus

Quarterly revenue - Rate of surprise